Crescendo Biologics Reaches First Major Milestone in Strategic Collaboration with Takeda
Crescendo Biologics Reaches First Major Milestone in Strategic Collaboration with Takeda view PDF
Entries by fr00fRoU
CEO Peter Pack interviewed by Scrip at Bio-Europe Spring 2018
CEO Peter Pack interviewed by Scrip at Bio-Europe Spring 2018 Crescendo aims to increase IO share of voice with Humabody platform
Crescendo Biologics Appoints Dani Bach as Non-Executive Director
Crescendo Biologics Appoints Dani Bach as Non-Executive Director view PDF
Crescendo Biologics to present poster at AACR Annual Meeting 2018, Chicago
Crescendo Biologics to present poster at AACR Annual Meeting 2018, Chicago view PDF
Crescendo Biologics’ Colette Johnston to present at 11th Annual Proteins & Antibodies Congress, London
Crescendo Biologics’ Colette Johnston to present at 11th Annual Proteins & Antibodies Congress, London view PDF
Crescendo Biologics’ James Legg to present at 4th Annual Crown Bioscience Cambridge Symposium
Crescendo Biologics’ James Legg to present at 4th Annual Crown Bioscience Cambridge Symposium view PDF
Crescendo Biologics to attend 12th Annual BIO-Europe Spring 2018, Amsterdam
Crescendo Biologics to attend 12th Annual BIO-Europe Spring 2018, Amsterdam view PDF
3rd Annual Advances in Immuno-Oncology Congress 2018, 24-24 May 2018
24-25 May 2018 3rd Annual Advances in Immuno-Oncology Congress 2018 James Legg to present and chair plenary session London
BioTrinity 2018
23-25 April 2018 BioTrinity 2018 Peter Pack and Brian McGuinness to attend London
11th Annual Proteins and Antibodies Congress 2018
16-17 April 2018 11th Annual Proteins and Antibodies Congress 2018 Colette Johnston to present London
Humabody® is a registered trademark of Crescendo Biologics Ltd.
